1-3 of 3
Armando Reyes-Palomares
Close
Sort by
Journal Articles

The Spliceosome As a New Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia

María Luz Morales, Roberto Garcia-Vicente, Alba Rodríguez García, Noemí Álvarez Sánchez-Redondo, Alejandra Ortiz-Ruiz, Armando Reyes-Palomares, Ricardo Sanchez, Vanesa Garrido-Garcia, Gonzalo Carreño-Tarragona, Sylvie Hermouet, Rosa Ayala, Joaquin Martinez Lopez, María Linares
Journal: Blood
Blood (2021) 138 (Supplement 1): 3334.
https://doi.org/10.1182/blood-2021-150879
Published: 2021
Journal Articles

Study of the Role of Splicing Factor SRRM2 in Cytarabine Treatment Resistance in Acute Myeloid Leukemia

María Luz Morales, Roberto Garcia-Vicente, Noemí Álvarez Sánchez-Redondo, Alba Rodríguez García, Alejandra Ortiz-Ruiz, Armando Reyes-Palomares, PhD, Sylvie Hermouet, MD PhD, Rosa Ayala, Joaquin Martinez-Lopez, MD PhD, María Linares
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-139338
Published: 2020
Journal Articles

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML

Swati Garg, Armando Reyes-Palomares, Lixiazi He, Anne Bergeron, Vincent-Philippe Lavallée, Sébastien Lemieux, Patrick Gendron, Christian Rohde, Jianglong Xia, Prarabdha Jagdhane, Carsten Müller-Tidow, Daniel B. Lipka, Suzan Imren, R. Keith Humphries, Claudia Waskow, Binje Vick, Irmela Jeremias, Guillaume Richard-Carpentier, Josée Hébert, Guy Sauvageau, Judith B. Zaugg, Frédéric Barabé, Caroline Pabst
Journal: Blood
Blood (2019) 134 (3): 263–276.
https://doi.org/10.1182/blood.2018862383
Published: 2019
Includes: Supplemental data